Medicinal HSA is approved for the substitution treatment of albumin loss, for example systemic capillary leakage or nephrotic syndromes, or general protein loss such as in burn injuries, as well as failure to generate sufficient albumin such as in liver failure [1, 3, 4]. Here, ALB is linked to Hepatic failure.